Log in
Sign Up. It's Free
Last Update: Oct, 28 2024
Overview
Dosage & Administration
Coverage
Drug label
PubMed™ News
Patient education
FAQ
Androderm
(testosterone)
DOSAGE FORMS & STRENGTHS
NO BOXED WARNING
See your patient’s PA requirements and coverage rules for
Androderm
Get Coverage Information
Get Patient Education Material
Dosage & Administration
* Prior to initiating ANDRODERM confirm the diagnosis of hypogonadism by ensuring that serum testosterone has been measured in the morning on at least two separate days and that these concentrations are below the normal range .
* The recommended starting dose is one ANDRODERM 4 mg/day system (not two 2 mg/day systems) applied nightly for 24 hours, delivering approximately 4 mg of testosterone per day.
* To ensure proper dosing, approximately 2 weeks after starting therapy, the early morning serum testosterone concentration should be measured following system application in the previous evening.
* Serum testosterone concentrations measured in the early morning outside the range of 400 - 930 ng/dL require increasing the daily dose to 6 mg (i.e., one 4 mg/day and one 2 mg/day system) or decreasing the daily dose to 2 mg (i.e., one 2 mg/day system), maintaining nightly application.
* Patients currently maintained on ANDRODERM 2.5 mg/day systems applied once daily may be switched to ANDRODERM 2 mg/day systems applied once daily in the evening at the next scheduled dose.
* Patients currently maintained on ANDRODERM 5 mg/day systems applied once daily may be switched to ANDRODERM 4 mg/day systems applied once daily in the evening at the next scheduled dose.
* Patients currently maintained on ANDRODERM 7.5 mg (2.5 mg/day and 5 mg/day systems) applied once daily may be switched to ANDRODERM 6 mg (2 mg/day and 4 mg/day systems) applied once daily in the evening at the next scheduled dose.
* To ensure proper dosing, approximately 2 weeks after switching therapy an early morning serum testosterone concentration should be measured following system application the previous evening.
Get Your Patient on Androderm
See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Insurance Carrier
Or select your Insurance from the list below:
UnitedHealthcare (UHC)
Aetna Health
CIGNA
Anthem Blue Cross and Blue Shield
TRICARE
Humana
Wellcare Health Plans
FEPBlue
VHA
UHC Community Plan
Androderm Prescribing Information
Contact Medical Science Liaison
Report Adverse Event
Androderm PubMed™ News
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
Androderm Patient Education
Getting started on Androderm
Instructions For Use: Low/No Testosterone
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.
Pull out phone
2.
Open camera
3.
Scan QR code with camera
4.
Tap link
Patient toolkit
About Androderm
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Androderm FAQs
How is the dosage of Androderm?
Androderm is available in 2 dosages, including 0.0833 mg/hr 24 HR Patch and 0.167 mg/hr 24 HR Patch
What does Androderm treat?
Androderm treats Breast Neoplasms, Hypogonadism and Puberty, Delayed
What is Androderm made of?
Androderm contains testosterone which is a Androgen
How Is Androderm Administered?
Androderm is administered as a Transdermal
What Are The Androderm Mechanism Of Action?
Androderm mechanism of action is Androgen Receptor Agonists
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available